1 not yet recruiting, 1 terminated, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 1, Terminated 1, Withdrawn 1 |
Follow Dr. Te Vuong: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal Cancer Nivolumab, HDRBET, Total Mesorectal Excision (TME) - Locally Advanced Rectal Cancer | Phase 2 | Not yet recruiting | Dr. Te Vuong | 10 | 2026-07-01 | 2026-06-12 |
| The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics Cysview - Colorectal Cancer, Photodynamic Diagnosis | Phase 2 | Withdrawn | Dr. Te Vuong | 2018-04-01 | 2019-09-18 | |
| Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers Nimotuzumab, Intensity Modulated Radiation Therapy (IMRT) - Squamous Cell Carcinoma of Anal Canal | Phase 2 | Terminated | Dr. Te Vuong | 1 | 2012-01-01 | 2013-01-28 |
5-aminolevulinic acid hexyl ester (1) · Nivolumab (1) · Radiotherapy, Intensity-Modulated (1) · nimotuzumab (1)
Canada (2)
Te Vuong, MD (1)